Detalles de la búsqueda
1.
Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial.
Lancet
; 401(10379): 821-832, 2023 03 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36774933
2.
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
N Engl J Med
; 384(9): 829-841, 2021 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33657295
3.
Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(2): 292-303, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35032437
4.
Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(7): 888-898, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35688173
5.
Analysis of female demographics in the United States: life expectancy, education, employment, family building decisions, and fertility service utilization.
Curr Opin Obstet Gynecol
; 33(3): 170-177, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33797423
6.
Status of racial disparities between black and white women undergoing assisted reproductive technology in the US.
Reprod Biol Endocrinol
; 18(1): 113, 2020 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33213467
7.
Correction to: Status of racial disparities between black and white women undergoing assisted reproductive technology in the US.
Reprod Biol Endocrinol
; 19(1): 117, 2021 Jul 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34330295
8.
Correction to: Status of racial disparities between black and white women undergoing assisted reproductive technology in the US.
Reprod Biol Endocrinol
; 18(1): 125, 2020 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33349258
9.
Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial.
Target Oncol
; 18(5): 639-641, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37659025
10.
Nivolumab plus ipilimumab plus cabozantinib triplet combination for patients with previously untreated advanced renal cell carcinoma: Results from a discontinued arm of the phase III CheckMate 9ER trial.
Eur J Cancer
; 177: 63-71, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36327527
11.
Disparities in ART Live Birth and Cumulative Live Birth Outcomes for Hispanic and Asian Women Compared to White Non-Hispanic Women.
J Clin Med
; 10(12)2021 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34198545
12.
Miscarriage determination in first trimester based on alpha-fetoprotein extracted from sanitary pads.
Fertil Steril
; 116(2): 462-469, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33461753
13.
A step towards the automation of intracytoplasmic sperm injection: real time confirmation of mouse and human oocyte penetration and viability by electrical resistance measurement.
Fertil Steril
; 113(1): 234-236, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31883732
14.
Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial.
Cancer Cell
; 38(4): 489-499.e3, 2020 10 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32916128
15.
Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma.
J Immunother Cancer
; 8(1)2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32503946
16.
Which Sleep Health Characteristics Predict All-Cause Mortality in Older Men? An Application of Flexible Multivariable Approaches.
Sleep
; 41(1)2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29165696
17.
Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma.
Eur J Cancer
; 86: 358-363, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29100190
18.
An approach to revealing clinically relevant subgroups across the mood spectrum.
J Affect Disord
; 203: 265-274, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27314813
Resultados
1 -
18
de 18
1
Próxima >
>>